PPBT
Purple Biotech
PPBT
PPBT
15 hedge funds and large institutions have $2.4M invested in Purple Biotech in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
44% less capital invested
Capital invested by funds: $4.25M → $2.4M (-$1.86M)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
15
Holding in Top 10
–
Calls
$593K
Puts
$809K
Top Buyers
| 1 | +$372K | |
| 2 | +$267K | |
| 3 | +$78K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$61K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$22.4K |
Top Sellers
| 1 | -$1.35M | |
| 2 | -$1.3M | |
| 3 | -$110K | |
| 4 |
Goldman Sachs
New York
|
-$100K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$79K |